Premium
Co‐overexpression of p21 and Ki‐67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis
Author(s) -
Fischer Claude A.,
Jung Minoa,
Zlobec Inti,
Green Edith,
Storck Claudio,
Tornillo Luigi,
Lugli Alessandro,
Wolfensberger Markus,
Terracciano Luigi M.
Publication year - 2011
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.21440
Subject(s) - medicine , radiation therapy , head and neck squamous cell carcinoma , immunohistochemistry , oncology , head and neck , basal cell , cell , ki 67 , head and neck cancer , cancer research , pathology , biology , surgery , genetics
Background. Head and neck squamous cell carcinomas (HNSCC) are treated by surgery or radiotherapy. Tumor cell death–related markers, such as p21 and Ki‐67, may predict response to therapy and improve treatment choice. We evaluated and compared the effect of their coexpression between patients treated by surgery or radiotherapy.Methods. Immunohistochemistry for p21 and Ki‐67 expression in 144 pharyngeal and laryngeal HNSCC samples was analyzed and correlated with follow‐up parameters.Results. p21 expression correlated significantly with positive cN classification ( p < .001), locoregional relapse ( p = .031), and poor overall survival ( p = .016), and Ki‐67 positivity with poor survival only ( p = .025). Coexpressing tumor phenotypes showed the worst survival ( p = .009), observed primarily in patients treated by radiotherapy ( p = .077).Conclusions. Coexpression of p21/Ki‐67 is a strong negative prognostic factor in HNSCC and could be of particular relevance in tumors treated by primary radiotherapy. © 2010 Wiley Periodicals, Inc. Head Neck, 2011